A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.
Also called NCT05144984
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT05144984 -
2020-004863-14
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Bulgaria, Denmark, Greece, Hungary, Japan, Poland, Russia, Serbia
- Registry status
- Completed
Technical summary
Registry record NCT05144984. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-29 (actual); primary completion 2023-02-13 (actual). Results posted on 2026-04-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- NNC0480-0389
- Intervention (Drug)
- Semaglutide
- Intervention (Drug)
- Placebo (NNC080-0389)
- Intervention (Drug)
- Placebo (semaglutide)
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct05144984- Content hash
47335105e87fe537bc7ef8585d1ba47aae8ecbcceadbb3d0c11dd5aacd471f81